SciDev.Net
Science and Development Network
News, views and information about science, technology and the developing world
Search Archive
Policy Briefs archive results 1-20 of 21 in Science & Innovation Policy
Innovation systems for agricultural development
An innovation systems approach to agricultural research can be better for sustainable development than a linear pipeline approach.
POLICY BRIEF | 22 May 2009 | EN
Working with foreign universities to build capacity
Sending students abroad and inviting in foreign institutions are both effective methods for boosting developing world higher education.
POLICY BRIEF | 11 March 2009 | EN
Putting adaptation at the heart of development
A four-step plan to help governments integrate adaptation to climate change into development planning and policy.
POLICY BRIEF | 11 December 2008 | EN
Reducing health and environmental risks of pesticides
Advice for policymakers in southern Africa on how to improve pesticide use and reduce the risks they pose to human health and the environment.
POLICY BRIEF | 6 November 2008 | EN
Opportunities and challenges in South–South collaboration
South–South research collaboration can be a powerful strategy for boosting scientific capacity and achieving common goals. But it should not be embraced uncritically, says Athar Osama.
Fostering technological capabilities in sub-Saharan Africa
Manufacturers in sub-Saharan Africa need policy support at all levels if their technological capabilities are to catch up with other developing countries. Carlo Pietrobelli looks at problems and solutions.
POLICY BRIEF | 1 November 2006 | EN
Malaria vaccines: research problems and priorities
Despite the urgent need for a malaria vaccine, progress in developing one has been slow and scientists do not always agree on the best way forward. This policy brief outlines the current status of malaria vaccine research.
POLICY BRIEF | 4 November 2005 | EN
How governments can boost business R&D
An outline of the financial and non-financial instruments that developing country governments can use to boost technology-generating efforts in production enterprises.
Building science, technology and innovation policies
How can developing countries construct national science, technology and innovation policies to enhance their development? This policy brief provides a guide to the issues involved.
POLICY BRIEF | 1 May 2005 | EN
After the trial is over: what are the sponsor's obligations?
What standard of care can clinical trial participants expect once the trial is over? Richard Ashcroft explores the ethical arguments for responsibilities of both researchers and sponsors of trials.
The role of universities in knowledge production
How can universities in developing countries change their roles in the production and distribution of knowledge to become 'developmental universities'?
POLICY BRIEF | 1 April 2005 | EN
Efforts to build capacity in research ethics: an overview
Sue Eckstein reviews existing schemes to build capacity in research ethics in developing countries, which range from sponsored academic degree programmes to tailored courses and one-off meetings.
POLICY BRIEF | 1 June 2004 | EN
The challenge of regulating international research with human subjects
James Lavery provides an introduction to the regulation of international human subjects research, describing the different approaches used, and highlighting some of the challenges faced.
POLICY BRIEF | 1 June 2004 | EN
Building capacity for ethical review in developing countries
Ethical review committees are the main way of ensuring that clinical research conforms to ethical standards. But, as Zulfiqar A. Bhutta explains, the work of such committees is severely constrained in many developing countries.
After a trial is over: the ethical issues
Brian Greenwood & William P. Hausdorff discuss the controversial area of what happens on completion of a clinical trial - in particular the extent of the ethical responsibilities of researchers and sponsors - and ways in which these responsiblities can be met.
POLICY BRIEF | 1 October 2003 | EN
Looking after participants in clinical trials
This policy brief explores one of the most contentious issues in research ethics, namely the level of treatment or other medical intervention – usually referred to as the ‘standard of care’ – that should be given to participants in clinical trials.
Bioprospecting: legitimate research or 'biopiracy'?
A growing number of critics of 'bioprospecting' complain that companies often fail to adequately compensate holders of traditional knowledge, and that patents on products developed in this way are actually a form of intellectual piracy.
Policy implications of the brain drain's changing face
A recent shift in thinking from “brain drain” to “brain circulation” suggests that the process is a normal one, and that the real challenge is not to block it, but to manage it as effectively as possible.
What impact do IPR rules have on food security?
An important issue raised by current debates on intellectual property rights — particularly in the context of their impact on developing countries — are the consequences that legislation protecting such rights may have for food security.
POLICY BRIEF | 1 October 2001 | EN
IPR rules and human rights: is there a conflict?
While intellectual property rights tend to be seen as primarily and economic or legal issue, it has been increasingly argued in recent years that there is also a broader 'human rights' dimension.
POLICY BRIEF | 1 October 2001 | EN
Information Services
Missed the Global Health Forum 2009?
Our blog, by SciDev.Net columnist Priya Shetty, will fill you in, as will our interview with the Global Forum's Gill Samuels
